SEARCH

SEARCH BY CITATION

References

  • Benowitz, N. L & P. Jacobs, III: Metabolism of nicotine to cotinine studied by dual stable isotope method. Clin. Pharmacol. Therap. 1994, 56, 483493.
  • Bæk, C., J. Hansen-Møller, C. Friis & S. H. Hansen: Identification and quantification of selected metabolites of skatole – possibilities for metabolic profiling of pigs. Proceedings of a meeting of the EAAP working group on production and utilization of meat from entire male pigs. Milton Keynes, UK, 1995, pp. 184(abstract).
  • Diaz, G. J & E. J. Squires: Metabolism of 3-methylindole by porcine liver microsomes: responsible cytochrome P450 enzymes. Toxicol. Sci. 2000, 55, 284292.
  • Fernandez-Salguero, P., S. M. G. Hoffman, S. Cholerton, H. Mohrenweiser, H. Raunio, A. Rautio, O. Pelkonen, J. Huang, W. E. Evans, J. R. Idle & F. J. Gonzales: A genetic polymorphism in coumarin 7-hydroxylation: sequence of the human CYP2A genes and icenditification of variant CYP2A6 alleles. Amer. J. Hum. Genet. 1995, 57, 651660.
  • Guengerich, F. P.: Human cytochrome P450 enzymes. In: Cytochrome P450. Ed.P. R.Ortiz de Montello. Plenum Press, New York, 1995, pp. 473535.
  • Hoffman, S. M. G., P. Fernandez-Salguero, F. J. Gonzales & H. W. Mohrenweiser: Organization and evolution of the cytochrome P450 CYP2A-2B -2F subfamily cluster on human chromosome 19. J. Mol. Evolut. 1995, 42, 894900.
  • Inoue, K., H. Yamazaki & T. Shimada: CYP2A6 genetic polymorphisms and liver microsomal coumarin and nicotine oxidation activities in Japanese and Caucasians. Arch. Toxicol. 2000, 73, 532539.
  • Le Gal, A., Y. Dreano, D. Lucas & F. Berthou: Diversity of selective environmental substrates for human cytochrome P450 2A6: alkoxyethers, nicotine, coumarin, N-nitrosodiethylamine, and N- nitrosobenzylmethylamine. Toxicol. Lett. 2003, 144, 7791.
  • Lewis, D. F. V. & G. G. Lake: Species differences in coumarin metabolism: a molecular modelling evaluation of CYP2A interactions. Xenobiotica 2002, 32, 547556.
  • Lewis, D. F. V., B. G. Lake, G. B. Lake, M. Dickins & P. S. Goldfarb: Homology modelling of CYP2A6 based on the CYP2A5 crystallographic template: enzyme-substrate interactions and QSARs for binding affinity and inhibition. Toxicol. in vitro 2003, 17, 179190.
  • Messina, E. S., R. F. Tyndal & E. M. Sellers: A major role for CYP2A6 in nicotine C-oxidation by human liver microsomes. J. Pharmacol. Exp. Therap. 1997, 282, 16081614.
  • Olsen, A. K., K. T. Hansen & C. Friis: Pig hepatocytes as an in vitro model to study the regulation of human CYP3A4: prediction of drug-drug interaction with 17 alfa-ethynylestradiol. Chem. Biol. Interact. 1997, 107, 93108.
  • Pelkonen, O., H. Raunio, M. Pasanen, A. Rautio & M. A. Land: The metabolism of coumarin. In: Coumarin biology, applications and mode of action. Ed.R.O`Kennedy, R. D.Thornes. Wiley, Chichester, 1995, pp. 6792.
  • Peterson, G. L.: A simplification of the protein assay method of Lowry et al., which is more generally applicable. Anal. Biochem. 1977, 38, 346356.
  • Shimada, T., H. Yamazaki, M. Mimura, Y. Inui & F. P. Guengerich: Interindividual variations in human liver cytochrome P450 enzymes involved in the oxidation of drugs, carcinogens and toxic chemicals. J. Pharmacol. Exp. Therap. 1994, 270, 414423.
  • Skaanild, M. T. & C. Friis: Cytochrome P450 sex differences in minipigs and conventional pigs. Pharmacology & Toxicology 1999, 851, 174180.
  • Tricker, A. R.: Nicotine metabolism, human drug metabolism polymorphisms, and smoking behaviour. Toxicology 2002, 183, 151173.
  • Van Iersel, M. D., G. Walters, R. J. Price, D. P. Lovell & B. G. Lake: Sex and strain differences in mouse hepatic microsomal coumarin 7-hydroxylase activity. Fd. Chem. Toxicol. 1994, 32, 387390.
  • http:www.imm.ki.se/CYPalleles/cyp2a6: CYP2A6 allele nomenclature.
  • Yamazaki, H., K. Inoue, M. Hashimoto & T. Shimada: Roles of CYP2A6 and CYP2B6 in nicotine C-oxidation by human liver microsomes. Arch. Toxicol. 1999, 73, 6570.
  • Xu, C., Y. S. Rao, B. Xu, E. Hoffmann, J. Jones, E. M. Sellers & R. F. Tyndale: An on vivo pilot study characterizing the new CYP2A6*7, *8, and *10 alleles. Biochem. Biophys. Res. Commun. 2002, 290, 318324.